Foamix Pharmaceuticals Email Format

Pharmaceutical ManufacturingCentral District, Israel11-50 Employees

Foamix Pharmaceuticals Ltd. is a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address dermatology needs. The company is based in Rehovot, Israel, at the Weizmann Science Park, operating as a small to mid-sized organization. It is listed on NASDAQ under the ticker FOMX, and its lead product candidates include FMX101, a minocycline foam for moderate-to-severe acne, and FMX103 for moderate-to-severe rosacea.

Its target market comprises patients and clinicians seeking topical treatments for dermatologic conditions, providing alternatives to systemic therapies. Within the pharmaceutical manufacturing sector, Foamix develops specialized topical foams intended to meet unmet dermatology needs. In January 2024, Foamix announced a collaboration with Lancashire County Council on a carbon-neutral asphalt material, representing a sustainability-focused development cited in the news.

Get verified Foamix Pharmaceuticals emails free

Company overview Employee directory